Clustering of coronary artery disease risk factors in patients with type 2 diabetes and impaired glucose tolerance

Eastern Mediterranean Health Journal

Volumn 14, Issue 5, 2008, Pages 1080-1089

  Sajjadi, F ^a   Mohammadifard, N ^a   Kelishadi, R ^a   Ghaderian, N ^a   Alikhasi, H ^a   Maghrun, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; EARLY DIAGNOSIS; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CLUSTER ANALYSIS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; EARLY DIAGNOSIS; FEMALE; GLUCOSE INTOLERANCE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYPERTENSION; IRAN; MALE; OBESITY; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; URBAN HEALTH;

EID: 55149095909     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Leroith D, Taylor SI, Olefsky JM, eds. Diabetes mellitus, 2nd ed. New York, Wolters Kluwer, 2000.
2. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes care, 1998, 21(2):296-309.
3. Azizi F. Modifying life style for the prevention of non-communicable disease. Iranian journal of endocrinology and metabolism, 2002, 4(2):81-4.
4. Kern PA et al. The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. New England journal of medicine, 1999, 322:1053-9.
5. Gaillard TR et al. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X. Diabetes care, 1997, 20:745-56.
6. Palmieri V et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects. Circulation, 2001, 103(1):102-7.
7. ERICA Research Group. Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA project. European heart journal, 1991, 12:291-7.
8. Sarraf-Zadegan N et al. Healthy heart program: a comprehensive integrated community-based program for cardiovascular disease prevention and control. Design, methods and initial experience. Acta cardiologia, 2003, 58(4):309-21.
9. National Institutes of Health/National Heart, Lung, and Blood Institute/ North American Association for the Study of Obesity. The practical guide. Identification, evaluation and treatment of overweigh and obesity in adults. Bethesda, Maryland, National Institutes of Health, 2000 (NIH Publication No. 00-4084).
10. Azizi F et al. Determinates of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose study. Nutrition, metabolism and cardiovascular diseases, 2002,12:80-9.
11. Wamick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clinical chemistry, 1982, 28(6):1379-88.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 1972, 18:499-502.
13. The Expert Committee of the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes, 2000, 25:S5-20.
14. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes care, 1993, 16:157-77.
15. Engelgau MM et al. Screening for NID-DM in nonpregnant adults. A review of principles, screening tests, and recommendations. Diabetes care, 1995, 18(12):1606-18.
16. Peters AL, Schriger DL. The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factors. American journal of medicine, 1998, 105(1A): 15S-9S.
17. Sarraf-Zadegan N, Sajjadi F. Hypertension and diabetes situation in the Eastern Mediterranean Region: with special reference to Iran. In: Dhalla NS et al., eds. Frontiers in cardiovascular health. Boston, Kluwer Academic, 2003.
18. Saad MF et al. The natural history of impaired glucose tolerance in the Pima Indians. New England journal of medicine, 1988, 319:1500-6.
19. Kannel W et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325, 348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. American heart journal, 1986, 112:825-36.
20. Pi-Sunyer FX. Type 2 diabetes outcomes. Obesity research, 2002, 10:22S-6S.
21. Ramachandran A et al. Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes care, 1998, 21(6):967-71.
22. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes, 1995, 44:369-74.
23. Niskanen L et al. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes care, 1998, 21:19-21.
24. Zimmet PZ et al. Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetic medicine, 1994, 11:388-96.
25. Hypertension in Diabetes Study (HDS). II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. Journal of hypertension, 1993, 11:319-25.
26. Jarrett RJ, Shipley MJ. Type 2 (noninsulin-dependent) diabetes mellitus and cardiovascular disease - putative association via common antecedents: further evidence from the Whitehall Study. Diabetologia, 1988, 31(10):737-40.
27. Doherty SC et al. Readiness to change health behaviours among patients at high risk of cardiovascular disease. Journal of cardiovascular risk, 1998, 5(3):147-53.
28. Guerci B et al. Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides. Clinical chemistry, 1999, 45(9):1439-48.
29. Lamarche B et al. Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease. Journal of the American Medical Association, 1998, 279:1955-61.
30. Kannel WB. High-density lipoproteins: epidemiologic profile and risks of coronary artery disease American journal of cardiology, 1983, 52:915-12b.
31. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obesity reviews, 2000, 1(1):47-56.
32. Leibson CL et al. Temporal trends in BMI among adults with diabetes. Diabetes care, 2001, 24(9):1584-9.
33. Azizi F et al. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000. Journal of human hypertension, 2002, 16(5):305-12.